Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MNDA | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | ADGRF4 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | PLEKHH1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | PYCARD | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | RTKN | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
mRNA | RAB7B | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | TREH | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | TMEM263 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
mRNA | SPI1 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
mRNA | LILRA2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |